Tokyo, Japan

Sakuo Noda

This inventor holds 11 USPTO granted patents. Top assignees: Kureha Kagaku Kogyo Kabushiki Kaisha, Kureha Chemical Industry Company, Limited. Active years: 1983-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sakuo Noda. Retrieved from https://idiyas.com/inventor/sakuo-noda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1983-1992

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Sakuo Noda: Innovator in Pharmaceutical Chemistry

Introduction

Sakuo Noda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on innovative compounds that have potential applications in medicine.

Latest Patents

Among his latest patents is a derivative of dihydroxybenzamide, which is represented by a specific formula. This compound includes variations where R¹ can be a hydrogen atom or a lower alkyl group, while R² can represent various alkyl and cyclo-alkyl groups. Additionally, he has developed saccharide derivatives of protocatechualdehyde, which are novel compounds that can serve as anti-inflammatory agents.

Career Highlights

Sakuo Noda has worked with notable companies such as Kureha Kagaku Kogyo Kabushiki Kaisha and Kureha Chemical Industry Company, Limited. His career has been marked by a commitment to advancing pharmaceutical research and development.

Collaborations

Throughout his career, Sakuo Noda has collaborated with esteemed colleagues, including Hitoshi Takita and Yutaka Mukaida. These partnerships have contributed to the success of his innovative projects.

Conclusion

Sakuo Noda's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…